In this issue

Channels
Volume 4, Issue 5
September/October 2010
View current issue
About the cover
Natarajan et al. present a bioinformatics (evolutionary correlation) and structural analysis of the interactions between the K V 1.2 channel and its β2...
Continue reading

Issue Highlights

Evolutionary Coupling in the KV1.2-β2 complex

Shreedhar Natarajan, Robert J. Mashl and Eric Jakobsson

Splice-variant changes of the CaV3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development

Laurence S. David, Esperanza Garcia, Stuart M. Cain, Elana Thau, John R. Tyson and Terrance P. Snutch

Random mutagenesis screening indicates the absence of a separate H+-sensor in the pH-sensitive Kir channels

Open Access Article
Jennifer J. Paynter, Lijun Shang, Murali K. Bollepalli, Thomas Baukrowitz and Stephen J. Tucker

The N-terminal domain of Orai3 determines selectivity for activation of the store-independent ARC channel by arachidonic acid

Open Access Article
Jill Thompson, Olivier Mignen and Trevor J. Shuttleworth

Table of Contents Alerts

Click here to begin receiving Channels Table of Contents via email.

HINARI

Landes Bioscience gladly participates in the World Health Organizations' Access to Research Initiative (HINARI) to provide free online access to all papers published in Channels to scientists in developing countries worldwide.

Read more about the HINARI initiative.

Editor-in-Chief

Gerald W. Zamponi
University of Calgary
Calgary, Canada

Email the Managing Editor.

Print ISSN: 1933-6950
Online ISSN: 1933-6969 DOI: 10.4161/chan

Most Popular Downloads

01 Jun 10
Fast, repetitive light-activation of CaV3.2 using Channelrhodopsin 2
Matthias Prigge, Anton Rösler and Peter Hegemann
01 Oct 10
The role of STEP in Alzheimer's disease
Pradeep Kurup, Yongfang Zhang, Deepa V. Venkitaramani, et al.
01 Jun 10
A conserved arginine near the filter of Kir1.1 controls Rb/K selectivity
Henry Sackin, Mikheil Nanazashvili, Hui Li, et al.
01 Oct 10

Submit your paper to Channels

Channels utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

Click here to submit your manuscript to Channels.

Channels is indexed in Medline/PubMed, Science Citation Index Expanded, Embase and Scopus.

About Channels

Channels is the first international peer-reviewed journal to focus exclusively on all aspects of ion channel and ion transporter/exchanger function. This includes papers on biophysics, structure, molecular biology, structure-function analysis, and regulation of channels and ion transport proteins, as well as their roles in health and disease. We also encourage submission of manuscripts concerned with physiological aspects that branch into areas such as neuroscience and cardiovascular sciences, provided that channels and/or transporters are the main focus of such studies. There are no limitations on technical and experimental approaches that will be considered.

The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional (print) as well as electronic formats (online). The overriding criteria for publication in Channels are originality, scientific merit and general interest. Channels is a bi-monthly publication. Channels is abstracted/indexed in PubMed/Medline, Scopus and Science Citation Index Expanded, Biochemistry and Biophysics Citation Index (available as Biological Abstracts and Biosis Previews).

Categories of manuscripts include original research, reviews, article addenda, commentaries and meeting reports. All manuscripts are sent for in depth peer review, however, the editorial board will consider reviewer reports from submissions to leading journals such as Nature, Science and Cell for accelerated review. Our goal is for Channels to become the leading journal in the ion channel and transporter fields.


Aurora Biomed, Inc. provides enabling technologies, assay services, and reagents for drug discovery research, drug safety screening, liquid-handling, and laboratory automation.

Advertisements